NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

Item
http://www.wikidata.org/entity/Q58010774
The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)Constitutive NF- κ B Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell LymphomaThe Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role?Tudor-SN Regulates Milk Synthesis and Proliferation of Bovine Mammary Epithelial CellsPrognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.Constitutive activation of alternative nuclear factor kappa B pathway in canine diffuse large B-cell lymphoma contributes to tumor cell survival and is a target of new adjuvant therapies.Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling.Mutational profile of primary breast diffuse large B-cell lymphoma.HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma.
P2860

NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

Item
http://www.wikidata.org/entity/Q58010774
description
scientific article published on 07 March 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2014
@uk
name
NFκB expression is a feature o ...... diffuse large B-cell lymphoma
@en
NFκB expression is a feature o ...... diffuse large B-cell lymphoma
@nl
type
label
NFκB expression is a feature o ...... diffuse large B-cell lymphoma
@en
NFκB expression is a feature o ...... diffuse large B-cell lymphoma
@nl
prefLabel
NFκB expression is a feature o ...... diffuse large B-cell lymphoma
@en
NFκB expression is a feature o ...... diffuse large B-cell lymphoma
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
NFκB expression is a feature o ...... diffuse large B-cell lymphoma
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698